| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |